Literature DB >> 32205033

Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels.

Vanessa Bianconi1, Maciej Banach2, Matteo Pirro3.   

Abstract

Familial hypercholesterolemia (FH) is a common genetic cause of elevated low-density lipoprotein cholesterol (LDL-C) due to defective clearance of circulating LDL particles. All FH patients are at high risk for premature cardiovascular disease (CVD) events due to their genetically determined lifelong exposure to high LDL-C levels. However, different rates of CVD events have been reported in FH patients, even among those with the same genetic mutations and comparable LDL-C levels. Hence, additional CVD risk modifiers, beyond LDL-C, may contribute to increase CVD risk in the FH population. In this review, we discuss the overall CVD risk burden of the FH population. Additionally, we revise the prognostic impact of several traditional and emerging predictors of CVD risk and we provide an overview of the role of specific tools to stratify CVD risk in FH patients in order to ensure them a more personalized treatment approach.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Familial hypercholesterolemia; Genetic; LDL-C; Phenotype; Predictor; Risk

Year:  2020        PMID: 32205033     DOI: 10.1016/j.tcm.2020.03.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  7 in total

1.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

2.  Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic.

Authors:  Maciej Banach; Peter E Penson; Zlatko Fras; Michal Vrablik; Daniel Pella; Željko Reiner; Seyed Mohammad Nabavi; Amirhossein Sahebkar; Meral Kayikcioglu; Magdalena Daccord
Journal:  Pharmacol Res       Date:  2020-05-07       Impact factor: 7.658

3.  Reducing cardiovascular disease risk among families with familial hypercholesterolaemia by improving diet and physical activity: a randomised controlled feasibility trial.

Authors:  Fiona Jane Kinnear; Fiona E Lithander; Aidan Searle; Graham Bayly; Christina Wei; David J Stensel; Alice E Thackray; Linda Hunt; Julian P H Shield
Journal:  BMJ Open       Date:  2020-12-28       Impact factor: 2.692

4.  Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.

Authors:  Sukma Azureen Nazli; Yung-An Chua; Noor Alicezah Mohd Kasim; Zaliha Ismail; Ahmad Bakhtiar Md Radzi; Khairul Shafiq Ibrahim; Sazzli Shahlan Kasim; Azhari Rosman; Hapizah Nawawi
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

5.  Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.

Authors:  Jean Ferrières; Victoria Banks; Demetris Pillas; Francesco Giorgianni; Laurene Gantzer; Beranger Lekens; Lea Ricci; Margaux Dova-Boivin; Jean-Vannak Chauny; Guillermo Villa; Gaelle Désaméricq
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

6.  Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia.

Authors:  Shiva Ganjali; Reihaneh Keshavarz; Susan Hosseini; Atena Mansouri; Massimo R Mannarino; Matteo Pirro; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2021-12-14       Impact factor: 4.241

7.  Genetic Polymorphisms in a Familial Hypercholesterolemia Population from North-Eastern Europe.

Authors:  Alexandra Maștaleru; Sabina Alexandra Cojocariu; Andra Oancea; Maria Magdalena Leon Constantin; Mihai Roca; Ioana Mădălina Zota; Irina Abdulan; Cristina Rusu; Roxana Popescu; Lucian Mihai Antoci; Cristian Gabriel Ciobanu; Alexandru Dan Costache; Elena Cojocaru; Florin Mitu
Journal:  J Pers Med       Date:  2022-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.